[1] Sadik CD, Schmidt E, Zillikens D, et al. Recent progresses and perspectives in autoimmune bullous diseases [J]. J Allergy Clin Immunol, 2020, 145(4): 1145-1147. [2] Kardos M, Levine D, Gürcan HM, et al. Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes [J]. Obstet Gynecol Surv, 2009, 64(11): 739-749. [3] Lan Y, Zhang H, Jin H. Pregnancy in pemphigus vulgaris: A systematic review [J]. Am J Reprod Immunol, 2024, 91(1): e13813. [4] Yang M, Wu H, Zhao M, et al. The pathogenesis of bullous skin diseases [J]. J Transl Autoimmun, 2019, 2: 100014. [5] Kershenovich R, Hodak E, Mimouni D. Diagnosis and classification of pemphigus and bullous pemphigoid [J]. Autoimmun Rev, 2014, 13(4-5):477-481. [6] Feliciani C, Genovese G, D'astolto R, et al. Autoimmune bullous diseases during pregnancy: insight into pathogenetic mechanisms and clinical features [J]. G Ital Dermatol Venereol, 2019, 154(3):256-262. [7] Singhal S, Meena J, Kumar S, et al. Maternal and perinatal outcomes of pregnancy in women with autoimmune disorder [J]. Cureus, 2021, 13(6): e16024. [8] Zhao CY, Chiang YZ, Murrell DF. Neonatal autoimmune blistering disease: A systematic review [J]. Pediatr Dermatol, 2016, 33(4): 367-374. [9] Joly P, Horvath B, Patsatsi A, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) [J]. J Eur Acad Dermatol Venereol, 2020, 34(9): 1900-1913. [10] Mahmoudi H, Toosi R, Salehi Farid A, et al. Pemphigus disease and area index: Unmet needs in the real-world management of pemphigus [J]. Oral Dis, 2024, 30(4):2275-2277. [11] Shamabadi A, Yazdinezhad S, Sadeghi Y, et al. ODSS vs. ABSIS and PDAI oral parts in pemphigus vulgaris: inter-rater reliability and testing times [J]. Oral Dis, 2023, 29(7):2696-2704. [12] Lin L, Zeng X, Chen Q. Pemphigus and pregnancy. Analysis and summary of case reports over 49 years [J]. Saudi Med J, 2015, 36(9):1033-1038. [13] 中国医疗保健国际交流促进会皮肤科分会. 寻常型天疱疮诊断和治疗专家建议(2020) [J]. 中华皮肤科杂志,2020,53(1):1-7. [14] 吴效科,黄志超.主译.舍费尔.著.孕期与哺乳期用药[M].北京:科学出版社,2021.1.302-304. [15] Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation [J]. Semin Arthritis Rheum, 2005, 35(2): 112-121. [16] Bostan E, Gülseren D, Ersoy Evans S, et al. Efficacious treatment of pemphigus vulgaris by intravenous immunoglobulin during pregnancy and postpartum period [J]. Dermatol Ther, 2020, 33(1):e13187. [17] Nasca MR, Giuffrida G, Micali G. The influence of pregnancy on the clinical evolution and prognosis of pre-existing inflammatory and autoimmune skin disorders and their management [J]. Dermatology, 2021, 237(5):771-785. [18] Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy [J]. J Am Acad Dermatol, 2014, 70(3): 401.e1-14; quiz 415. |